This is a discussion on Tysabri policy criteria - Crohn's disease within the Managed Care Issues for Injectable Drugs forum, part of the Managed Care Drug Coverage category; To respond to your interest in this topic, we updated our review to include analysis of criteria for Crohn’...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
||||
|
To respond to your interest in this topic, we updated our review to include analysis of criteria for Crohn’s Disease (click on the image to enlarge it).
![]() Of note, a search of Crohn's disease guidelines did not mention Tysabri because they were issued before the approval of Tysabri for CD: American Gastroenterological Association Medical Position Statement: Perianal Crohn’s Disease (2003) American College of Gastroenterology: Crohn's disease in adults (2001) Related link: Tysabri policy criteria - MS Last edited by chantell.reagan : 10-04-2008 at 02:39 PM. |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Tysabri policy criteria | chantell.reagan | Managed Care Issues for Injectable Drugs | 0 | 09-25-2008 01:53 PM |
| Amgen Stops Rebates for Darbepoetin, Alters Discount Policy | industry_news | Other Clinical Pharmacy News | 0 | 09-05-2008 12:23 PM |
| Forteo policy criteria | sdpharmd | Managed Care Issues for Injectable Drugs | 2 | 08-21-2008 01:19 PM |
| Maintenance With Infliximab Effective in Crohn's Disease | industry_news | Other Clinical Pharmacy News | 0 | 07-21-2008 10:51 AM |
| FDA approves Cimzia to treat Crohn's disease | industry_news | FDA News | 0 | 04-22-2008 03:11 PM |